Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel…

By P. Emery, F. Breedveld, S. Hall, P. Durez, D. Chang, D. Robertson, Amitabh Singh, R. Pedersen, A. Koenig, B. Freundlich. The Lancet, 2008

802 citations recorded by the source corpus.

Subfields: Rehabilitation, Rheumatology

View Paper: https://www.semanticscholar.org/paper/1d72dde35bea8ae56328a0802a293d5cfaa2680e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

1. Daniel Aletaha
2. J. Smolen
3. I. McInnes
4. S. Gaffen

Citations in the corpus

• Treating rheumatoid arthritis to target: recommendations of an international task force (2010, neutral): “31 32 The recommendations are primarily meant to provide guidance on ways towards this goal, as seen by experts.”
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (2010, positive): “…that in the vast majority of patients with RA the fi rst treatment approach should include synthetic DMARDs, since a signifi cant proportion of patients can attain a state of very low disease activity or remission 36–39 ; the types of DMARD with evidence of effi cacy will be discussed in items 3–6.”